when does semaglutide go off patent With semaglutide's expiring, generics are set to enter from soon, setting competition in a fast-growing segment of obesity and diabetes care. https://timesofindia.indiatimes.com/toi-plus/business-economy/why-miracle-weight-loss-drugs-are Novo Nordisk Settles Ozempic Patent

The first true oral GLP-1 competitor, orforglipron (Eli Lilly, brand name Foundayo), is a non-peptide agonist expected to launch at a significantly lower price point

In another trial, patients who reduced their Zepbound dose to a lower 5 mg maintenance dose also preserved much of their earlier weight reduction compared with those who stopped treatment entirely

A warning about counterfeit and unlicensed retatrutide Despite not being licensed, retatrutide is already being sold illegally online and, in some cases, through pharmacies operating outside the rules

Compounded drugs are not approved by the FDA and are not required to undergo the same safety and effectiveness testing as brand-name medications